FDA Continues to Push for RFID
In order to protect against prescription drug counterfeiting, FDA Commissioner Andrew von Eschenbach reiterated his agency's support for an e-Pedigree program featuring RFID technology at last week's RFID in Healthcare Industry Adoption Summit, held here in Washington, DC. The Commissioner noted that electronic tracking of drugs would be far more secure than simply having a paper trail, saying "FDA can no longer indefinitely delay having pedigrees".
Earlier this month, we saw the FDA's support for electronic drug tracking hit some resistance from federal courts, as noted in this blog before.
Earlier this month, we saw the FDA's support for electronic drug tracking hit some resistance from federal courts, as noted in this blog before.